rs61748497
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PP3PM2_SupportingPM3PS3PP4_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_000552.5(VWF):c.3178T>C (p.Cys1060Arg) missense variant is absent from gnomAD v4.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.96, which is above the ClinGen VWD VCEP threshold of >0.644 and predicts a damaging effect on VWF function (PP3). At least one homozygote and two compound heterozygotes with R854Q (confirmation of trans phase not reported), which is classified pathogenic by the VWD VCEP (PMID:12588349; PM3). At least 1 patient with this variant displayed excessive mucocutaneous bleeding as well as low FVIII activity (FVIII:C 4-10 IU/dL) and absent VWF:FVIII binding, which is highly specific for VWD type 2N. (PP4_moderate, PMID 12406074). Variants in F8 were screened for by sequencing. Site-directed mutagenesis and transient expression in COS-7 cells showed R1060rVWF was completely unable to bind to rFVIII (PMID:12588349; PS3). In summary, this variant meets the criteria to be classified as Pathogenic for von Willebrand disease type 2N. ACMG/AMP criteria applied as specified by the ClinGen von Willebrand disease Variant Curation Expert Panel: PM2_supporting, PP3, PM3, PP4_moderate, PS3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA114176/MONDO:0015631/090
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 25
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
von Willebrand disease type 2N Pathogenic:2
- -
The NM_000552.5(VWF):c.3178T>C (p.Cys1060Arg) missense variant is absent from gnomAD v4.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.96, which is above the ClinGen VWD VCEP threshold of >0.644 and predicts a damaging effect on VWF function (PP3). At least one homozygote and two compound heterozygotes with R854Q (confirmation of trans phase not reported), which is classified pathogenic by the VWD VCEP (PMID: 12588349; PM3). At least 1 patient with this variant displayed excessive mucocutaneous bleeding as well as low FVIII activity (FVIII:C 4-10 IU/dL) and absent VWF:FVIII binding, which is highly specific for VWD type 2N. (PP4_moderate, PMID 12406074). Variants in F8 were screened for by sequencing. Site-directed mutagenesis and transient expression in COS-7 cells showed R1060rVWF was completely unable to bind to rFVIII (PMID: 12588349; PS3). In summary, this variant meets the criteria to be classified as Pathogenic for von Willebrand disease type 2N. ACMG/AMP criteria applied as specified by the ClinGen von Willebrand disease Variant Curation Expert Panel: PM2_supporting, PP3, PM3, PP4_moderate, PS3. -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at